CLINICAL_TRIALS trial_result · 2024-11-12

Clinical Trial Update: Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T) [Phase 4]

A Phase 4 clinical trial update on refining regimens for ultra-short therapy in multidrug-resistant tuberculosis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Huashan Hospital | Conditions: Multidrug Resistant Tuberculosis | Phase 4 | Status: COMPLETED